Cathy Emmas

955 total citations
18 papers, 478 citations indexed

About

Cathy Emmas is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Cathy Emmas has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Cathy Emmas's work include Atrial Fibrillation Management and Outcomes (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Cathy Emmas is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Cathy Emmas collaborates with scholars based in United Kingdom, United States and Sweden. Cathy Emmas's co-authors include Nicky Richards, Iain M. Carey, Derek G. Cook, Stephen DeWilde, Una Rigney, Steven J Edwards, Helen Campbell, Adam Timmis, Allan H. Young and Jill M. Thompson and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and BMJ.

In The Last Decade

Cathy Emmas

17 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy Emmas United Kingdom 12 218 65 64 60 58 18 478
Candice L. Garwood United States 16 246 1.1× 86 1.3× 120 1.9× 66 1.1× 36 0.6× 44 692
Chandrasekar Gopalakrishnan United States 13 114 0.5× 72 1.1× 34 0.5× 59 1.0× 28 0.5× 28 553
Stephen Kogut United States 15 133 0.6× 93 1.4× 27 0.4× 58 1.0× 110 1.9× 67 729
Mary Loverde United States 10 165 0.8× 30 0.5× 84 1.3× 88 1.5× 60 1.0× 13 643
Frits R. Rosendaal Netherlands 3 100 0.5× 36 0.6× 30 0.5× 43 0.7× 26 0.4× 4 373
Karolina Obońska Poland 15 319 1.5× 33 0.5× 28 0.4× 140 2.3× 19 0.3× 36 578
Michał Kasprzak Poland 15 317 1.5× 38 0.6× 15 0.2× 103 1.7× 45 0.8× 65 686
Srečko Marušić Croatia 15 128 0.6× 79 1.2× 19 0.3× 39 0.7× 24 0.4× 38 568
Joshua Feinberg Denmark 15 194 0.9× 211 3.2× 33 0.5× 82 1.4× 25 0.4× 39 792
Ricky D. Turgeon Canada 13 353 1.6× 60 0.9× 41 0.6× 176 2.9× 13 0.2× 93 721

Countries citing papers authored by Cathy Emmas

Since Specialization
Citations

This map shows the geographic impact of Cathy Emmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Emmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Emmas more than expected).

Fields of papers citing papers by Cathy Emmas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Emmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Emmas. The network helps show where Cathy Emmas may publish in the future.

Co-authorship network of co-authors of Cathy Emmas

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Emmas. A scholar is included among the top collaborators of Cathy Emmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Emmas. Cathy Emmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Potter, Danielle, Aliki Taylor, Cathy Emmas, et al.. (2021). Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database. JCO Clinical Cancer Informatics. 5(5). 658–667. 9 indexed citations
4.
James, Glen, Anna Niklasson, Katarina Hedman, et al.. (2020). Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study. Journal of Medical Internet Research. 22(7). e18548–e18548. 12 indexed citations
5.
6.
Wicks, Paul, et al.. (2018). Scaling PatientsLikeMe via a “Generalized Platform” for Members with Chronic Illness: Web-Based Survey Study of Benefits Arising. Journal of Medical Internet Research. 20(5). e175–e175. 26 indexed citations
7.
Wilding, John, et al.. (2017). Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. Primary care diabetes. 11(5). 437–444. 24 indexed citations
8.
Timmis, Adam, Eleni Rapsomaniki, Sheng‐Chia Chung, et al.. (2016). Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations. BMJ. 353. i3163–i3163. 12 indexed citations
9.
Wilding, John, Clifford J. Bailey, Una Rigney, et al.. (2016). Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study. Diabetes Therapy. 7(4). 695–711. 21 indexed citations
10.
Pasea, Laura, Sheng‐Chia Chung, Mar Pujades‐Rodríguez, et al.. (2015). DEVELOPMENT AND VALIDATION OF PROGNOSTIC MODELS FOR MYOCARDIAL INFARCTION, STROKE AND CARDIOVASCULAR DEATH AND HOSPITALISED BLEEDING IN STABLE MYOCARDIAL INFARCTION SURVIVORS. Journal of the American College of Cardiology. 65(10). A1382–A1382. 1 indexed citations
11.
Bakhai, Ameet, et al.. (2012). Co‐administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Pharmacoepidemiology and Drug Safety. 21(5). 485–493. 30 indexed citations
12.
Boggon, Rachael, Tjeerd van Staa, Adam Timmis, et al.. (2011). Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD). European Heart Journal. 32(19). 2376–2386. 70 indexed citations
13.
Young, Allan H., et al.. (2011). Annual cost of managing bipolar disorder to the UK healthcare system. Journal of Affective Disorders. 133(3). 450–456. 52 indexed citations
14.
Edwards, Steven J, Mary Clarke, Sarah Wordsworth, & Cathy Emmas. (2008). Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials. European Journal of Clinical Microbiology & Infectious Diseases. 27(7). 531–543. 9 indexed citations
15.
DeWilde, Stephen, Iain M. Carey, Cathy Emmas, Nicky Richards, & Derek G. Cook. (2005). Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart. 92(8). 1064–1070. 138 indexed citations
16.
Edwards, Steven J, Cathy Emmas, & Helen Campbell. (2005). Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections. Current Medical Research and Opinion. 21(5). 785–794. 34 indexed citations
17.
Currie, Craig J., Phil McEwan, Cathy Emmas, Christopher Ll. Morgan, & John R. Peters. (2005). Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population. Current Medical Research and Opinion. 21(12). 1905–1913. 22 indexed citations
18.
Tait, Robert C., et al.. (2005). PCV14 THE COST OF ANTICOAGULATION MONITORING SERVICES IN THE UK NATIONAL HEALTH SERVICE. Value in Health. 8(6). A92–A92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candice L. Garwood Breakdown of academic impact, for papers by Chandrasekar Gopalakrishnan Breakdown of academic impact, for papers by Stephen Kogut Breakdown of academic impact, for papers by Mary Loverde Breakdown of academic impact, for papers by Frits R. Rosendaal Breakdown of academic impact, for papers by Karolina Obońska Breakdown of academic impact, for papers by Michał Kasprzak Breakdown of academic impact, for papers by Srečko Marušić Breakdown of academic impact, for papers by Joshua Feinberg Breakdown of academic impact, for papers by Ricky D. Turgeon
Rankless by CCL
2026